$ICPT BO is not likely but maybe somthing like 15% - 20% chance in next 3 months. There is always the possibility that Ocaliva doesn't ever earn indication for NASH but still most viable anti-sclerosing treatment available with no major serious adverse events. Pruritis is not even a factor as most with liver disease.. live with anyways. once these folks become encephalopathic (triphasic wave periodic EEG pattern) they experience significant pruritis anyways. This may even increase target price 150's
  • 1
1 Like